Skip to main content

Table 5 Common potentially inappropriate medications with renal contraindications, dose adjustments, or precautions for the study population

From: Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease

Medications that are both PIM and RIMGroup of drugDCIPatients n (%)
 Central hypertensive drugRilmenidine92 (16.5)
 Central hypertensive drugMoxonidine9 (1.6)
 Central hypertensive drugClonidine6 (1.1)
 Central hypertensive drugMethyldopa1 (0.2)
 Long-term benzodiazepineLorazepam31 (5,6)
 Long-term benzodiazepineBromazepam17 (3.1)
 Long-term benzodiazepineClonazepam14 (2.5)
 Long-term benzodiazepineClorazepate8 (1.4)
 Long-term benzodiazepineLormetazepam6 (1.1)
 Long-term benzodiazepineClobazam5 (0.9)
 Long-term benzodiazepinePrazepam3 (0.5)
 Long-term benzodiazepineClotiazepam2 (0.4)
 Long-term benzodiazepineLoprazolam2 (0.4)
 Long-term benzodiazepineEthylloflazepate1 (0.2)
 Anticholinergic drugHydroxyzine27 (4.9)
 Anticholinergic drugMirtazapine9 (1.6)
 Anticholinergic drugAmitriptyline4 (0.7)
 Anticholinergic drugDexchlorpheniramine3 (0.5)
 Anticholinergic drugAlimemazine2 (0.4)
 Anticholinergic drugRopinirole1 (0.2)
 VasodilatorBuflomedil20 (3.6)
 VasodilatorPentoxifylline3 (0.5)
 OtherDigoxin10 (1.8)
 OtherOpium+Cafeine+paracetamol5 (0.9)
 OtherBaclofen1 (0.2)
 OtherNitrofurantoin1 (0.2)
\